Evidence map›Paper›PMID 37276191›Full record

ArticleThe American journal of case reports2023

A Multimodal Approach to Laser Treatment of Extensive Hypertrophic Burn Scar: A Case Report.

Piero Campolmi, Lavinia Quintarelli, Irene Fusco

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Sequential Fractional COJournal of clinical medicine · 2025
    Review
  4. Burn scar pain: from mechanisms to treatments.Frontiers in physiology · 2025
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Piero CampolmiDermatologist, Firenze, Italy.
Lavinia QuintarelliSection of Dermatology, Department of Health Sciences, University of Florence, Firenze, Italy.ORCID 0000-0002-9228-8042
Irene FuscoClinical Research and Practice, El.En. Group, Florence, Italy.
El.En. Group (Italy) · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Hypertrophic scars from severe burns cause physical and psychological stress. Proper treatment, including CO₂ laser systems, can alleviate these burdens by enabling skin remodeling and collagen production. This study assessed the efficacy of a new laser device with 2 wavelengths (10 600 nm/1540 nm) and 2 scanning units on hypertrophic burn scar management. CASE REPORT A 34-year-old African woman sought treatment for a large hypertrophic burn scar on her right foot. The scar, formed at age 9, was complicated by infection. She underwent 2 CO₂ sessions (Scar3 scanner), followed by 3 cycles of fractional CO₂ +1540 nm laser (µScan DOT scanner) once a month, combined with topical hyaluronic acid. She also had 2 maintenance sessions with a 595-nm dye laser to prevent scar reactivation. The CO₂ and 1540 nm laser synergy improved laxity through volumetric thermal effects, causing contraction and stimulation. This led to a softer, smaller scar with less consistency. The patient experienced significant improvement in quality of life due to alleviation of pain and restored footwear comfort. CONCLUSIONS The hypertrophic burn scar was effectively treated using 10 600 nm and 1540 nm wavelengths, along with dye laser treatment for recurrence prevention.

Indexed as

BurnsCicatrix, HypertrophicLasers, GasLaser TherapyAdultCarbon DioxideChildFemaleHumansHypertrophyQuality of LifeTreatment OutcomeCarbon Dioxide

Identifiers

PMID37276191
PMCPMC10254085
OpenAlexW4367842077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.